Stuff that matters
New findings by researchers at Yale Cancer Center show the drug combination of nivolumab and rucaparib shows clinical activity for patients with chemotherapy-naïve, metastatic castration resistant prostate cancer (mCRPC). The findings are part of the CheckMate 9KD trial and will Read more
In human cancer cell and mouse studies, researchers from Johns Hopkins Medicine have found that a set of proteins work in tandem to build supply lines that deliver oxygen and nutrients to tumors, enabling them to survive and grow. The Read more
New research from the University of Cambridge suggests that autistic individuals are less likely to identify as heterosexual and more likely to identify with a diverse range of sexual orientations than non-autistic individuals. The findings have important implications for the Read more
University of Minnesota Medical School graduate students analyzed and summarized literature on the health effects of chemical demonstration control agents, such as tear gas, including the studies which informed existing exposure guidelines. Their study shows that, despite frequent use around Read more
Therapy with babies boosts social development, reducing clinical autism diagnosis by two-thirdsA parent-led intervention that supports the social development of babies displaying early signs of autism has significantly reduced the likelihood of an autism diagnosis being made in early childhood, Read more
NMDAR antibody encephalitis is a disease that predominately affects children and young adults. The disease occurs when antibodies perturb the function of the N-methyl-D-aspartate (NMDA) receptor in the brain, required for controlling thoughts, moods and movements. The disease causes seizures, Read more
In one of the first studies to explore clinician moral distress related to the ethically challenging provision of healthcare to undocumented immigrants, researchers from Regenstrief Institute and Indiana University School of Medicine surveyed physicians and nurses to assess their perspectives Read more